Form D · Pharmaceuticals

ARYx Therapeutics, Inc.

Fremont, CA · CIK 0001410064

Offering snapshot reported Aug 30, 2010 · SEC filing

Reported sold: $2.01M
Investors reported: 7
Minimum accepted: $0
First sale: Aug 13, 2010

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 30, 2010	Initial	$2,012,500	No comparison	7	SEC filing
Nov 13, 2009	Initial	$357,446	No comparison	1	SEC filing
Nov 28, 2008	Paper	Not reported	No comparison	Not reported	SEC filing
Nov 28, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-147064

Total offering amount includes $4,000,000 in secured promissory notes, $25,000 for the purchase price of the warrants and $1,000,000 for the future exercise price of the warrants.

Source: Form D, filed Aug 30, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
David Beier	Director
Daniel Canafax	Executive
Pascal Druzgala	Executive
Lars Ekman	Director
Paul Goddard	Director, Executive
Keith Leonard	Director
Peter G. Milner	Director, Executive
David Nagler	Executive
Hermn Rosenman	Director
Herm Rosenman	Director
Paul Sekhri	Director
Nick Simon	Director
N Ick Simon	Director
John Varian	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

6300 Dumbarton Circle
Fremont, CA, 94555